Chase Coleman III
Tiger Global Management
Chase Coleman III Myriad Genetics Inc stake
total: 436
Tiger Global Management MYGN trades
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2013 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2015 Q2
According to 2026 Q2 report, Chase Coleman III doesn't hold any Myriad Genetics Inc (MYGN) shares. To date, the estimated cost basis is nearly $27.42 for "buy" trades and estimated average "sell" price is $36.07. Tiger Global Management first purchased MYGN in 2013 Q4, initially acquiring about 1.20M shares. Since the initial investment in Myriad Genetics Inc (MYGN), Tiger Global Management has made 4 more transactions.
When did Chase Coleman III sell Myriad Genetics Inc (MYGN)?
Chase Coleman III sold off the entire Myriad Genetics Inc (MYGN) position in 2015 Q2.
When did Chase Coleman III buy Myriad Genetics Inc (MYGN)?
Chase Coleman III first invested in Myriad Genetics Inc (MYGN) in 2013 Q4 at the reported quarter-end price of $20.98 per share.
What's the cost basis of Tiger Global Management's MYGN stake?
The estimated cost basis for Myriad Genetics Inc (MYGN) stake is around $27.42 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $27.42
- Weighted AVG sell price:
- $36.07
Chase Coleman III's historical trades in Myriad Genetics Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q2
|
0.00%
|
$35.40
|
-100% (-291,097)
|
|||
|
2015 Q1
|
0.11%
|
$35.40
|
-84.68% (-1,608,903)
|
|||
|
2014 Q2
|
1.04%
|
$38.92
|
-19.01% (-445,921)
|
|||
|
2014 Q1
|
1.09%
|
$34.19
|
+95.15% (+1,143,821)
|
|||
|
2013 Q4
|
0.32%
|
$20.98
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.